HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,752,936 | +6.4% | 53,058 | +1.1% | 0.02% | +11.1% |
| Q2 2023 | $4,467,466 | +16.9% | 52,472 | +13.6% | 0.02% | +5.9% |
| Q1 2023 | $3,820,899 | +548.7% | 46,174 | +516.6% | 0.02% | +466.7% |
| Q4 2022 | $589,010 | +20.2% | 7,489 | +1.9% | 0.00% | +50.0% |
| Q2 2021 | $490,000 | -37.1% | 7,349 | +4.8% | 0.00% | -50.0% |
| Q1 2021 | $779,000 | -6.5% | 7,015 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $833,000 | -9.2% | 7,015 | -33.2% | 0.00% | 0.0% |
| Q3 2020 | $917,000 | -67.1% | 10,505 | -66.3% | 0.00% | -69.2% |
| Q2 2020 | $2,789,000 | -16.8% | 31,146 | -7.5% | 0.01% | -38.1% |
| Q1 2020 | $3,354,000 | -13.2% | 33,659 | +0.1% | 0.02% | +10.5% |
| Q4 2019 | $3,865,000 | -15.7% | 33,634 | -7.5% | 0.02% | -24.0% |
| Q3 2019 | $4,585,000 | -14.5% | 36,345 | -18.4% | 0.02% | -13.8% |
| Q2 2019 | $5,360,000 | +19.5% | 44,538 | -13.1% | 0.03% | +16.0% |
| Q1 2019 | $4,486,000 | -17.7% | 51,278 | -5.9% | 0.02% | -26.5% |
| Q4 2018 | $5,453,000 | -13.8% | 54,498 | -1.3% | 0.03% | +3.0% |
| Q3 2018 | $6,328,000 | +18.8% | 55,228 | -7.0% | 0.03% | +13.8% |
| Q2 2018 | $5,326,000 | +39.1% | 59,393 | +13.5% | 0.03% | +31.8% |
| Q1 2018 | $3,830,000 | +27.5% | 52,350 | +1.2% | 0.02% | +37.5% |
| Q4 2017 | $3,004,000 | -13.7% | 51,720 | -33.3% | 0.02% | -20.0% |
| Q3 2017 | $3,481,000 | +63.6% | 77,569 | +43.9% | 0.02% | +53.8% |
| Q2 2017 | $2,128,000 | +213.4% | 53,889 | +222.1% | 0.01% | +160.0% |
| Q1 2017 | $679,000 | -14.9% | 16,729 | -15.7% | 0.01% | -16.7% |
| Q4 2016 | $798,000 | -34.3% | 19,853 | -40.8% | 0.01% | -40.0% |
| Q3 2016 | $1,214,000 | +28.1% | 33,518 | +2.5% | 0.01% | +25.0% |
| Q2 2016 | $948,000 | -27.1% | 32,703 | -11.3% | 0.01% | -38.5% |
| Q2 2014 | $1,300,000 | +25.6% | 36,855 | +16.0% | 0.01% | +18.2% |
| Q1 2014 | $1,035,000 | -56.8% | 31,760 | -44.1% | 0.01% | -59.3% |
| Q4 2013 | $2,394,000 | +30.1% | 56,815 | +23.1% | 0.03% | +17.4% |
| Q3 2013 | $1,840,000 | +18.3% | 46,145 | +22.7% | 0.02% | +4.5% |
| Q2 2013 | $1,555,000 | – | 37,610 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |